Related Experiment Video

Updated: Aug 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Sudden death and hypertrophic cardiomyopathy: a review

Hung Q Ly1, Isabelle Greiss, Mario Talakic

  • 1Clinical Electrophysiology Service, Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.

The Canadian Journal of Cardiology
|April 30, 2005
PubMed

Insights

Identifying high-risk patients with hypertrophic cardiomyopathy (HCM) is crucial for preventing sudden cardiac death. Advanced tools now aid in risk stratification and guide prophylactic treatment with implantable cardioverter-defibrillators.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder characterized by myocardial hypertrophy and disarray.
  • Patients with HCM face an increased risk of malignant ventricular tachyarrhythmias and sudden cardiac death.
  • Accurate identification of high-risk individuals is paramount for effective sudden cardiac death prevention.

Purpose of the Study:

  • To review current strategies for identifying patients with hypertrophic cardiomyopathy at high risk of sudden cardiac death.
  • To discuss the utility of various risk stratification tools, including clinical factors, echocardiography, and genetic testing.
  • To highlight the role of implantable cardioverter-defibrillators in the prophylactic management of high-risk HCM patients.

Main Methods:

  • Review of clinical risk factors associated with sudden cardiac death in HCM.
  • Evaluation of echocardiographic parameters, specifically left ventricular hypertrophy.
  • Assessment of the prognostic significance of genetic mutations in hypertrophic cardiomyopathy.
  • Analysis of the efficacy of implantable cardioverter-defibrillators in primary and secondary prevention.

Main Results:

  • Established clinical risk factors include age, syncope, family history, cardiac arrest, nonsustained ventricular tachycardia, and abnormal exercise blood pressure response.
  • Echocardiographic assessment of left ventricular hypertrophy and identification of prognostically significant genetic mutations are increasingly important.
  • Clinical electrophysiological studies have limited utility in risk stratification for HCM.
  • Implantable cardioverter-defibrillator therapy demonstrates effectiveness in reducing sudden cardiac death in both primary and secondary prevention.

Conclusions:

  • Effective tools are now available for identifying high-risk patients with hypertrophic cardiomyopathy.
  • Implantable cardioverter-defibrillators have become the standard for prophylactic treatment in high-risk individuals.
  • A comprehensive approach combining clinical, imaging, and genetic data is essential for optimal risk stratification and management.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...